GlassScriptPhysician profile
Barry Lee Green
NPI 1033156112
$1,195.50
in general payments reported to CMS, 2019-2025
15 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $264 · 2021: $180 · 2022: $118 · 2023: $160 · 2024: $77.44 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $265.69 | 2019-2023 | |
| Exeltis, USA INC. | $248.00 | 2020-2025 | Slynd, Tyblume |
| Therapeuticsmd, INC. | $162.62 | 2020-2022 | |
| Millicent US INC | $87.04 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Minerva Surgical, INC | $83.78 | 2019 | |
| Organon LLC | $49.18 | 2022-2024 | |
| Allergan, INC. | $45.97 | 2019-2020 | |
| Sage Therapeutics, LLC | $43.08 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $41.31 | 2020-2025 | Fluent Fluid Management System |
| Avion Pharmaceuticals | $40.47 | 2019-2022 | |
| Roche Diagnostics Corporation | $28.63 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $28.50 | 2019 | |
| Lupin INC. | $26.59 | 2020 | |
| Sumitomo Pharma America, INC. | $26.49 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $18.15 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.